Cargando…
Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors
Infectious complications are a major cause of morbidity and mortality in patients with hemato-oncological diseases. Although disease-related immunosuppression represents one factor, aggressive treatment regimens, such as chemotherapy, stem cell transplantation, or antibody treatment, account for a l...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Libertas Academica
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841329/ https://www.ncbi.nlm.nih.gov/pubmed/27127405 http://dx.doi.org/10.4137/BMI.S22430 |